SPATS2L and atrial fibrillation: First, while our cross‐tissue TWAS‐MR framework identified SPATS2L and CEP68 as potential AF susceptibility genes through functional prioritization, the molecular mechanisms underlying these associations require experimental validation using cellular models and in vivo systems.